Summary
In vivo anaphylaxis is associated with respiratory distress and cardiovascular failure. The present investigation was designed to further characterize respiratory and cardiac anaphylactic events. In guinea pigs, sensitization was produced by subcutaneous application of ovalbumin together with Freund's adjuvant. Fourteen days after sensitization, the effects of an intravenous infusion of ovalbumin were tested in the anesthetized artificially ventilated guinea pigs. The renewed application of the antigen induced an initial increase of left ventricular pressure which was followed by a rapid decrease 5 min after antigenic challenge. Enddiastolic left ventricular pressure increased within 3 min, thus indicating left ventricular pump failure. In the same time range, ECG recordings uniformly showed signs of acute myocardial ischemia. In addition, heart rate steadily decreased. All animals died within 15 min. Simultaneously with cardiac anaphylactic malfunction, severe arterial hypoxia and carbon dioxide retention occurred, revealing respiratory distress.
Histamine is known as a potent bronchoconstrictor via histamine H1-receptor stimulation. Administration of H1-recpetor antagonists to improve respiration may therefore provide further information on the contribution of pulmonary malfunction to anaphylactic cardiovascular shock. Therefore, additional experiments were performed with sensitized guinea pigs pretreated with the histamine H1-receptor blocker mepyramine. In these experiments the antigenic challenge induced a dissociation of cardiac and respiratory manifestation of anphylaxis. Despite inhibition of hypoxia and carbon dioxide retention, left ventricular pump failure and occurrence of myocardial ischemia were delayed but not suppressed.
It is concluded that histamine is an important mediator of anaphylactic respiratory distress. However, vasoactive anaphylactic mediators other than histamine are primarily involved in anaphylactic cardiac malfunction occurring during the later phase of systemic anaphylaxis.
Similar content being viewed by others
References
K. Greeff, B. G. Benfey and A. Bokelmann,Anaphylaktische Reaktionen am isolierten Herzvorhofpräparat des Meerschweinchens und ihre Beeinflussung durch Antihistaminika, BOL, Dihydroergotamin und Reserpin. Naunyn-Schmiedeberg's Arch. Exp. Path. Pharmakol.236, 421–434 (1959).
G. A. Feigen and D. J. Prager,Experimental cardiac anaphylaxis. Physiologic, pharmacologic and biochemical aspects of immune reactions in the isolated heart. Am. J. Cardiol.24, 474–491 (1969).
R. Levi,Effect of exogenous and immunologically released histamine on the isolated heart: A quantitative comparison. J. Pharmacol. Exp. Ther.182, 227–238 (1972).
R. Levi,Cardiac anaphylaxis: Models, mediators, mechanisms, and clinical considerations. InHuman inflammatory disease, clinical immunology. Vol. 1, pp. 93–105 (eds. G. Marone, L. M. Lichtenstein, M. Condorelli, A. S. Fauci). B. C. Decker, Inc., Toronto 1988.
N. Capurro and R. Levi,The heart as a target organ in systemic allergic reactions. Comparison of cardiac anaphylaxis in vivo and in vitro. Circ. Res.36, 520–528 (1975).
E. T. Nishimura, R. Patterson, J. N. Fink and J. N. Wennemark,Myocardial lesions associated with experimental passive transfer of immediate type hypersensitivity. Lab. Invest.15, 1269–1278 (1966).
R. Patterson, J. N. Fink, J. Wennemark, J. Baum, J. Pruzansky and E. T. Nishimura,The biologic consequences of the immediate type hypersensitivity transferred from man to monkey. J. Allergy37, 295–310 (1966).
S. B. Felix, G. Baumann and W. E. Berdel,Systemic anaphylaxis — separation of cardiac reactions from respiratory and peripheral vascular events. Res. Exp. Med.190, 239–252 (1990).
W. Lorenz and A. Doenicke,H 1 and H 2 Blockade: A prophylactic principle in anesthesia and surgery against histamine-release responses of any degree of severity: Part I. N. Engl. Res. Allerg. Proc.6, 38–57 (1985).
W. Lorenz and A. Doenicke,H 1 and H 2 Blockade: A prophylactic principle in anesthesia and surgery against histamine-release responses of any degree of severity: Part II. N. Engl. Res. Allerg. Proc.6, 174–192 (1985).
J. Joad and T. B. Casale,Histamine and airway caliber. Ann. Allergy.61, 1–7 (1988).
G. Neumann, W. Erhardt, B. Oberhuber, R. Fritsch and G. Blümel,A new highly potent and short-acting analgesic, Carfentanyl (R33799) in combination with the hypnotic agent Etomidat (R26490), as a method of analgesia in guinea pigs. Res. Exp. Med.177, 135–143 (1980).
K. Pavek, A. Wegmann, L. Nordström and D. Schwander,Cardiovascular and respiratory mechanisms in anaphylactic and anaphylactoid shock reactions. Klin. Wochenschr.60, 941–947 (1982).
H. J. Silvermann, C. Van Hook and E. F. Haponik,Hemodynamic changes in human anaphylaxis. Am. J. Med.77, 341–344 (1984).
R. F. Raper and M. McD. Fisher,Profound reversible dial depression after anaphylaxis. Lancet1, 386–388 (1988).
B. H. Booth and R. Patterson:Electrocardiographic changes during human anaphylaxis. J.A.M.A.211, 627–631 (1970).
L. H. Criep and T. R. Woehler,The heart in human anaphylaxis. Ann. Allergy29, 399–409 (1971).
H. D. Levine,Acute myocardial infarction following wasp sting: report of two cases and critical survey of the literature. Am. Heart J.91, 365–374 (1976).
M. N. Druck, D. E. Johnstone, H. Staniloff and P. R. McLaughlin,Coronary artery spasm as a manifestation of anaphylactoid reaction to iodinated contrast material. Can. Med. Assoc. J.125, 1133–1135 (1981).
D. Antonelli, B. Koltun and J. Barzilay,Transient ST segment elevation during anaphylactic shock. Am. Heart J.108, 1052–1054 (1984).
E. S. K. Assem,Anaphylactic reactions affecting the human heart. Agents and Actions27, 142–145 (1989).
R. Levi, N. Capurro and C.-H. Lee,Pharmacological characterization of cardiac histamine receptors: sensitivity to H 1-and H2-receptors agonists and antagonists. Eur. J. Pharmacol.30, 328–335 (1975).
J. H. McNeil and S. C. Verma,Blockade by burimamide of the effects of histamine and histamine analogs on cardiac contractility, phosphorylase activation and cyclic adenosine monophosphate. J. Pharmacol. Exp. Ther.188, 180–188 (1974).
G. Baumann, S. B. Felix, J. Schrader, C. D. Heidecke, G. Riess, W. D. Erhardt, L. Ludwig, U. Loher, F. Sebening and H. Blömer,Cardiac contractile and metabolic effects mediated via the myocardial H 2-receptor adenylate cyclase system. Res. Exp. Med.179, 81–98 (1981).
M. R. Bristow, R. Ginsburg and D. C. Harrison,Histamine and the human heart: The other receptor system. Am. J. Cardiol.49, 249–251 (1982).
G. R. Hageman, F. Urthaler, J. H. Isobe and T. N. James,Chronotropic and dromotropic effects of histamine on the canine heart. Chest75, 597–604 (1979).
G. Baumann, U. Loher, S. B. Felix, C. D. Heidecke, G. Riess, L. Ludwig and H. Blömer,Deleterious effects of cimetidine in the presence of histamine on coronary circulation. Possible clinical implications in anaphylactic states in individuals with coronary heart disease. Res. Exp. Med.180, 209–213 (1982).
R. Ginsburg, M. R. Bristow, K. Davis, A. Dibiase and M. E. Billingham,Quantitative pharmacologic responses of normal and atherosclerotic isolated human epicardial coronary arteries. Circulation69, 430–440 (1984).
C. A. Tozzi, S. G. Dorrell and G. F. Merril,Evidence of histamine-induced myocardial ischemia: reversal by chlorpheniramine and potentiation by atherosclerosis. Cardiovasc. Res.19, 744–753 (1985).
N. Toda,Mechanism of histamine actions in human coronary arteries. Circ. Res.61, 280–286 (1987).
Author information
Authors and Affiliations
Additional information
Supported by grant Fe 250/1-1 from the Deutsche Forschungsgemeinschaft (DFG).
Rights and permissions
About this article
Cite this article
Felix, S.B., Baumann, G., Hashemi, T. et al. Effects of histamine H1-receptor blockade on respiratory and cardiac manifestation of systemic anaphylaxis. Agents and Actions 33, 349–358 (1991). https://doi.org/10.1007/BF01986585
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01986585